NVIDIA Corp (NVDA)
195.21
-3.48 (-1.75%)
NASDAQ · Last Trade: Nov 5th, 5:28 PM EST
Detailed Quote
| Previous Close | 198.69 |
|---|---|
| Open | 198.77 |
| Bid | 196.25 |
| Ask | 196.27 |
| Day's Range | 194.65 - 202.92 |
| 52 Week Range | 86.62 - 212.19 |
| Volume | 167,913,630 |
| Market Cap | 4.76T |
| PE Ratio (TTM) | 55.46 |
| EPS (TTM) | 3.5 |
| Dividend & Yield | 0.0400 (0.02%) |
| 1 Month Average Volume | 179,396,505 |
Chart
About NVIDIA Corp (NVDA)
NVIDIA Corporation is a leading technology company primarily known for its innovations in graphics processing units (GPUs) that enhance visual computing across various applications, including gaming, professional visualization, and artificial intelligence. Beyond its strong presence in gaming, NVIDIA's products are integral to deep learning and data center solutions, empowering advancements in machine learning, autonomous vehicles, and high-performance computing. By leveraging its cutting-edge technologies, NVIDIA aims to drive the future of computing and improve experiences across industries, from entertainment to scientific research. Read More
News & Press Releases
Mobile app technology company AppLovin (NASDAQ:APP) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 17.3% year on year to $1.41 billion. Its GAAP profit of $2.45 per share was 2.6% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
Payment technology company Marqeta (NASDAQ:MQ) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 27.6% year on year to $163.3 million. On top of that, next quarter’s revenue guidance ($167 million at the midpoint) was surprisingly good and 5.6% above what analysts were expecting. Its GAAP loss of $0.01 per share was in line with analysts’ consensus estimates.
Via StockStory · November 5, 2025
Aerospace and defense company Redwire (NYSE:RDW) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 50.7% year on year to $103.4 million. The company’s full-year revenue guidance of $330 million at the midpoint came in 21.9% below analysts’ estimates. Its GAAP loss of $0.29 per share was 93.3% below analysts’ consensus estimates.
Via StockStory · November 5, 2025
Energy recovery device manufacturer Energy Recovery (NASDAQ:ERII) reported Q3 CY2025 results topping the market’s revenue expectations, but sales fell by 17.1% year on year to $32 million. Its non-GAAP profit of $0.12 per share was 24.1% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
Ride sharing service Lyft (NASDAQ: LYFT) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 10.7% year on year to $1.69 billion. Its GAAP profit of $0.11 per share was 53.6% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
Refrigerant services company Hudson Technologies (NASDAQ:HDSN) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 19.5% year on year to $74.01 million. Its GAAP profit of $0.27 per share was 40.3% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
Healthcare distributor and services company McKesson (NYSE:MCK) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 10.1% year on year to $103.2 billion. Its non-GAAP profit of $9.86 per share was 8.9% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
Business payments company Corpay (NYSE:CPAY) announced better-than-expected revenue in Q3 CY2025, with sales up 13.9% year on year to $1.17 billion. The company’s full-year revenue guidance of $4.52 billion at the midpoint came in 1.3% above analysts’ estimates. Its non-GAAP profit of $5.70 per share was 1% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
Customer experience software company CSG Systems (NASDAQ:CSGS) met Wall Streets revenue expectations in Q3 CY2025, with sales up 2.9% year on year to $303.6 million. Its non-GAAP profit of $1.31 per share was 17.3% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 6.7% year on year to $1.13 billion. The company expects the full year’s revenue to be around $4.23 billion, close to analysts’ estimates. Its non-GAAP profit of $8.13 per share was 39% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
Buy-now-pay-later service Sezzle (NASDAQCM:SEZL) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 67% year on year to $116.8 million. Its GAAP profit of $0.75 per share was 15.4% above analysts’ consensus estimates.
Via StockStory · November 5, 2025
As November 2025 unfolds, the financial markets are grappling with a complex and often contradictory narrative emanating from the Federal Reserve. The central bank has recently embarked on a path of monetary easing, delivering two consecutive 25-basis-point rate cuts in September and October, bringing the federal funds rate to a
Via MarketMinute · November 5, 2025
The October 2025 ADP National Employment Report has injected a fresh wave of complexity into the Federal Reserve's delicate balancing act, revealing a private sector that added 42,000 jobs – a figure significantly surpassing economists' projections. This unexpected surge in employment, the first monthly gain since July, arrives amidst a
Via MarketMinute · November 5, 2025
Microsoft Gets $135 Billion OpenAI Stakefool.com
Via The Motley Fool · November 5, 2025
Kicking off financial results for quantum computing stocks, IonQ reported a bigger than expected Q3 loss while revenue topped expectations.
Via Investor's Business Daily · November 5, 2025
IREN shares are trading higher Wednesday after the company recently signed a $9.7 billion AI cloud services agreement with Microsoft to deploy NVIDIA GB300 GPUs across its 750 MW Texas campus.
Via Benzinga · November 5, 2025
The global stock market in November 2025 presents a fascinating dichotomy, a landscape where robust year-to-date gains clash with mounting concerns over stretched valuations and a palpable shift in investor sentiment. While major indices have enjoyed a remarkably strong year, propelled by an insatiable appetite for artificial intelligence (AI) innovation
Via MarketMinute · November 5, 2025
The financial markets, still reeling from a tumultuous period marked by significant downturns, are now grappling with an uneasy attempt at consolidation. As of November 5, 2025, investors are witnessing a landscape fundamentally altered by a series of sharp slides, most notably the tariff-induced crash of April 2025 and a
Via MarketMinute · November 5, 2025
SPXL and TQQQ both offer daily 3x leveraged exposure, but SPXL focuses on the S&P 500 while TQQQ targets the tech-heavy Nasdaq-100, leading to deeper drawdowns for TQQQ.
Via The Motley Fool · November 5, 2025
Shares of content discovery platform Taboola (NASDAQ:TBLA) jumped 5.5% in the morning session after the company reported strong third-quarter financial results that surpassed expectations and provided an optimistic forecast for the upcoming quarter. Revenue for the quarter reached $496.8 million, growing 14.7% year on year and comfortably beating analysts' forecasts. The company also swung to a profit, with GAAP earnings of $0.02 per share, which was ahead of Wall Street's expectations and a notable improvement from the loss of $0.02 per share recorded in the prior year's quarter. Looking ahead, Taboola's revenue guidance for the fourth quarter was also surprisingly strong, coming in 3.3% above consensus estimates. Overall, it was a solid quarter for the company, highlighted by broad-based beats and a strong outlook.
Via StockStory · November 5, 2025
Shares of self defense company AXON (NASDAQ:AXON)
fell 18.5% in the morning session after the company reported third-quarter results that missed profit expectations and provided weak EBITDA guidance for the upcoming quarter. While revenue for the quarter grew 30.6% year-on-year to $710.6 million, beating Wall Street's estimates, investors focused on the negatives. The company's adjusted earnings per share of $1.17 came in 24.1% below the consensus estimate of $1.54. Furthermore, Axon's EBITDA guidance for the fourth quarter was below analyst expectations. The company also saw its operating margin contract, falling to -0.3% from 4.4% in the same quarter last year, indicating rising expenses were outpacing revenue growth. Despite the earnings miss, the company's revenue guidance for the next quarter was slightly ahead of forecasts.
Via StockStory · November 5, 2025
The financial markets as of November 5, 2025, present a compelling dichotomy with the technology and pharmaceutical sectors charting distinct yet largely positive courses. While technology continues its robust ascent, fueled by the insatiable demand for Artificial Intelligence (AI) and its underlying infrastructure, the pharmaceutical sector demonstrates a resilient recovery,
Via MarketMinute · November 5, 2025
The financial markets are currently navigating a complex and often contradictory economic landscape, heavily influenced by a suite of critical indicators such as jobs data and the Purchasing Managers' Index (PMI). From late 2024 through November 2025, these barometers of economic health have signaled a period of deliberate rebalancing, characterized
Via MarketMinute · November 5, 2025
The global financial markets are currently gripped by a palpable sense of unease, as significant stock swings and heightened volatility define the investment landscape of late 2025. This turbulent period is primarily driven by a complex interplay of geopolitical tensions, evolving interest rate expectations, and lingering concerns over inflated valuations
Via MarketMinute · November 5, 2025
The U.S. stock market has entered November 2025 with a complex narrative, characterized by both robust bullish momentum and burgeoning concerns over valuations, particularly within the high-flying technology sector. Major global stock market indices – the Dow Jones Industrial Average (DJIA), Nasdaq Composite, and S&P 500 – have exhibited a
Via MarketMinute · November 5, 2025